infect
herp
simplex
viru
hsv
human
cytomegaloviru
hcmv
lead
lifethreaten
diseas
particularli
immunosuppress
patient
furthermor
hsv
infect
birth
herp
neonatorum
result
dissemin
diseas
associ
fatal
multiorgan
failur
congenit
hcmv
infect
result
miscarriag
seriou
birth
defect
development
disabl
antibodybas
intervent
hyperimmunoglobulin
show
encourag
result
clinic
studi
clearli
need
improv
isol
highli
neutral
monoclon
antibodi
promis
strategi
establish
potent
therapi
option
hsv
hcmv
infect
monoclon
antibodi
commonli
isol
hybridoma
ebvimmort
bcell
clone
screen
procedur
identifi
virusspecif
cell
cell
mixtur
challeng
step
sinc
highli
neutral
antibodi
target
complex
conform
epitop
viru
surfac
convent
assay
elisa
base
purifi
viral
protein
inappropri
display
complex
epitop
overcom
obstacl
establish
two
fullviru
base
method
allow
screen
cell
antibodi
target
complex
conform
epitop
viral
surfac
antigen
method
suitabl
detect
surfac
antigenspecif
cell
cell
mixtur
may
facilit
isol
highli
neutral
antibodi
hsv
hcmv
neutral
antivir
antibodi
becom
potent
tool
treatment
prevent
sever
viral
infect
past
decad
marasco
sui
polyclon
immunoglobulin
g
igg
prepar
deriv
immun
human
donor
use
wide
rang
viral
infect
human
cytomegaloviru
hcmv
respiratori
syncyti
viru
rsv
hepat
b
viru
hbv
rabi
viral
infect
et
al
howev
efficaci
prepar
limit
sinc
virusspecif
neutral
antibodi
minor
proport
total
pool
polyclon
serumderiv
antibodi
marasco
sui
develop
hybridoma
technolog
product
monoclon
antibodi
milstein
mile
stone
antibodi
field
led
isol
numer
monoclon
antibodi
mab
kohler
milstein
numer
potent
antivir
monoclon
antibodi
influenza
viru
human
immunodefici
viru
hiv
hepat
c
viru
hcv
ebola
viru
sever
acut
respiratori
syndromerel
coronaviru
sarscov
virus
caus
danger
infect
isol
current
clinic
studi
even
approv
antivir
treatment
bornholdt
et
al
et
al
caskey
et
al
kwong
et
al
pelegrin
et
al
traggiai
et
al
human
monoclon
antibodi
isol
bcell
patient
recov
diseas
eg
sar
ebola
longterm
control
chronic
infect
eg
hiv
herpesvirus
sever
technolog
avail
includ
immort
human
bcell
epsteinbarr
viru
ebv
ali
et
al
traggiai
et
al
gener
stabl
human
hybridoma
yu
et
al
direct
clone
heavi
light
antibodi
chain
vh
vl
gene
phage
express
librari
diebold
et
al
mark
et
al
mccafferti
et
al
gener
monoclon
antibodi
singl
human
bcell
singl
cell
pcr
tiller
et
al
wardemann
et
al
mani
strategi
timeconsum
labori
case
work
ebvimmort
bcell
hybridoma
cell
sort
antigenspecif
donor
bcell
prior
cultur
significantli
facilit
identif
rare
bcell
secret
neutral
antibodi
kodituwakku
et
al
morri
et
al
potzsch
et
al
zhang
et
al
purpos
donor
bcell
presort
flow
cytometri
techniqu
use
recombin
viral
glycoprotein
strategi
highli
promis
target
antigen
neutral
antibodi
known
viru
incorpor
one
two
surfac
glycoprotein
potenti
target
neutral
antibodi
eg
ebola
case
complex
virus
like
human
cytomegaloviru
hcmv
herp
simplex
virus
hsv
enrich
antigenspecif
bcell
may
highli
challeng
particularli
target
antigen
exactli
known
herpesvirus
use
complex
entri
machineri
consist
numer
glycoprotein
connolli
et
al
sathiyamoorthi
et
al
four
viral
glycoprotein
gb
gd
gh
gl
requir
suffici
entri
host
cell
agelidi
shukla
hcmv
use
two
distinct
pathway
enter
host
cell
gb
repres
fusion
protein
two
differ
glycoprotein
complex
control
cell
tropism
viru
ghglgo
trimer
involv
infect
cell
type
pentam
addit
requir
infect
endotheli
epitheli
myeloid
cell
kabanova
et
al
vanarsdal
johnson
zhou
et
al
neutral
antibodi
target
complex
often
bind
conformationdepend
epitop
bender
et
al
chandramouli
et
al
ciferri
et
al
gardner
et
al
macagno
et
al
ohlin
et
al
wussow
et
al
obvious
critic
factor
success
isol
monoclon
antibodi
blood
donor
proper
screen
strategi
crucial
element
detect
strategi
highli
specif
antibodyantigen
interact
prerequisit
identifi
antibodi
use
correctli
fold
antigen
antigen
complex
issu
may
simpl
virus
use
one
glycoprotein
cell
entri
eg
ebola
challeng
herpesvirus
use
highli
complex
entri
machineri
therefor
convent
screen
strategi
base
singl
recombin
protein
may
unsuit
identifi
antibodiesbcel
specif
antigen
de
alwi
et
al
jone
et
al
prior
studi
shown
dengu
viru
neutral
antibodi
target
complex
epitop
exist
correct
conform
state
surfac
virion
particl
recombin
solubl
antigen
smith
et
al
promis
strategi
improv
recoveri
rare
neutral
antibodi
complex
epitop
inclus
whole
virusbas
screen
ebvimmort
bcell
hybridoma
standard
antibodi
isol
protocol
prior
amplif
vhvl
gene
antibodi
product
present
studi
describ
two
distinct
method
identif
antigenspecif
cell
secret
virusspecif
antibodi
direct
hsv
hcmv
method
may
facilit
isol
highli
neutral
antibodi
target
complex
conform
epitop
hybridoma
cell
line
secret
b
gb
specif
monoclon
antibodi
mab
cell
gener
fusion
bcell
balbc
mice
hyperimmun
strain
hv
murin
myeloma
cell
maintain
iscov
modifi
dulbecco
medium
imdm
life
technolog
gibco
darmstadt
germani
previous
describ
eishubing
et
al
hybridoma
cell
produc
murin
friend
viru
specif
monoclon
antibodi
kindli
provid
ulf
dittmer
institut
virolog
essen
germani
cell
cultur
roswel
park
memori
institut
medium
rpmi
thermo
fisher
scientif
waltham
usa
vero
cell
american
type
cultur
collect
atcc
rockvil
md
cultur
dulbecco
modifi
eagl
medium
dmem
thermo
fisher
scientif
media
supplement
vv
fetal
bovin
serum
fb
thermo
fisher
scientif
uml
penicillin
mgml
streptomycin
thermo
fisher
scientif
hybridoma
cell
line
secret
hcmvgh
specif
monoclon
antibodi
see
supplement
fig
origin
hybridoma
cell
librari
gener
fuse
hcmvimmun
mous
bcell
myeloma
cell
line
accord
standard
polyethylen
glycol
peg
fusion
procedur
falk
et
al
hybridoma
cell
line
secret
monoclon
antibodi
specif
hcmvtegument
phosphoprotein
describ
previous
britt
auger
cell
line
cultur
rpmi
medium
supplement
fetal
bovin
serum
panbiotech
aidenbach
germani
gentamicin
sigmaaldrich
darmstadt
germani
sigmaaldrich
murin
interleukin
peprotech
hamburg
germani
primari
human
foreskin
fibroblast
hff
cultur
mem
supplement
glutamax
life
technolog
gibco
fetal
bovin
serum
panbiotech
ngml
basic
fibroblast
growth
factor
bfgf
life
technolog
gibco
gentamicin
sigmaaldrich
infect
bfgf
omit
hffmedium
denot
stabli
transfect
cell
secret
specif
human
antibodi
mab
cultur
dmem
contain
vv
fetal
bovin
serum
fb
thermo
fisher
scientif
uml
penicillin
mgml
streptomycin
thermo
fisher
scientif
multipl
myeloma
cell
kindli
provid
ralf
institut
cell
biolog
tumor
research
essen
germani
cell
secret
human
monoclon
antibodi
specif
cultur
rpmi
contain
vv
fetal
bovin
serum
fb
thermo
fisher
scientif
uml
penicillin
mgml
streptomycin
thermo
fisher
scientif
gener
cell
transient
express
human
antihcmv
antibodi
cell
highli
transfect
deriv
human
primari
embryon
kidney
cell
line
dsmz
transfect
transfect
system
biontex
munich
germani
two
plasmid
encod
heavi
light
chain
human
igg
neutral
antibodi
direct
hcmv
pentamer
complex
macagno
et
al
egfpencod
plasmid
takara
mountain
view
usa
use
control
transfect
effici
around
supernat
cell
specif
neutral
endotheli
cell
infect
intend
shown
cell
cultur
dmem
life
technolog
gibco
supplement
fetal
bovin
serum
panbiotech
gentamicin
sigmaaldrich
recombin
fcreceptor
delet
herp
simplex
viru
describ
previous
farnsworth
et
al
kindli
provid
hartmut
hengel
institut
virolog
freiburg
germani
propag
titrat
vero
cell
viru
stock
contain
tcid
ml
uv
inactiv
min
uv
analysi
lamp
nm
herolab
wiesloch
germani
store
thaw
stock
use
coat
microtit
plate
gfpexpress
report
viru
seegfp
gener
describ
previous
selfexcis
baccassett
gfp
express
control
shorten
iepromotor
sampaio
et
al
antibodi
product
cell
cultur
serumfre
condit
excel
serumfre
medium
sigmaaldrich
supplement
uml
penicillin
mgml
streptomycin
thermo
fisher
scientif
monoclon
antibodi
mab
mab
purifi
serumfre
cellcultur
supernat
protein
chromatographi
thermo
scientif
worcest
usa
previous
describ
krawczyk
et
al
krawczyk
et
al
dialyz
phosphatebuff
salin
pb
micropl
plate
greiner
bio
one
austria
coat
uv
inactiv
overnight
immobil
viru
fix
paraformaldehyd
pfa
carl
roth
karlsruh
germani
ten
minut
wash
three
time
pb
nonspecif
bind
block
pb
contain
bsa
life
technolog
gibco
h
room
temperatur
subsequ
plate
wash
three
time
pb
immobil
incub
differ
number
murin
hybridoma
cell
secret
monoclon
antibodi
mab
cell
secret
human
counterpart
mab
antibodi
recogn
conform
epitop
gb
cell
dilut
cultur
medium
supplement
fb
uml
penicillin
mgml
streptomycin
respect
control
either
murin
cell
human
multipl
myeloma
cell
ad
unspecif
control
reach
total
number
cellswel
cultur
incub
h
plate
wash
five
time
pb
contain
tween
therebi
lyse
cell
order
remov
cell
unbound
antibodi
bound
antibodi
detect
use
ultrasensit
abc
mous
igg
stain
kit
thermo
fisher
scientif
cat
kit
includ
goatantimous
gam
iggspecif
biotinconjug
secondari
antibodi
bound
secondari
antibodi
incub
avidinhorseradish
peroxidas
hrp
complex
maxim
signal
secondari
antibodi
combin
avidinperoxidas
complex
incub
h
room
temperatur
follow
wash
three
time
pb
tween
kit
use
detect
bound
human
mab
secondari
antibodi
replac
biotin
conjug
goatantihuman
gah
iggspecif
secondari
antibodi
cat
jacksonimmunoreseacrh
cambridgeshir
uk
tmbelisa
substrat
thermo
fisher
scientif
incub
min
characterist
colour
chang
detect
reaction
stop
sulfur
acid
applichem
darmstadt
germani
signal
measur
spectrophotometri
berthold
technolog
bad
wildbad
germani
nm
cutoff
defin
valu
pb
control
determin
detect
limit
assay
serial
dilut
nm
purifi
monoclon
antibodi
mab
mab
incub
coat
plate
h
bound
antibodi
detect
describ
determin
sensit
virusbas
elisa
assay
decreas
concentr
nm
mab
mab
incub
coat
plate
bound
antibodi
measur
describ
murin
friend
virusspecif
control
antibodi
human
antibodi
specif
use
gener
background
valu
dilut
nm
identif
hcmvspecif
cell
antibodyfootprint
assay
detect
hcmvspecif
hybridoma
cell
micropl
highbind
black
greiner
bio
one
coat
goat
f
antimous
igg
specif
jackson
immunoresearch
west
grove
pa
usa
mm
carbon
buffer
ph
overnight
nonspecif
bind
block
pb
contain
milk
powder
sigma
aldrich
h
room
temperatur
block
solut
remov
trypan
blue
sigmaaldrich
use
count
hybridoma
cell
henc
exclud
dead
cell
vari
number
hcmv
ghspecif
cell
eg
mix
cell
serv
unspecif
control
reach
total
number
cellswel
hybridoma
cell
seed
rpmi
medium
life
technolog
gibco
supplement
fetal
bovin
serum
panbiotech
gentamicin
sigmaaldrich
sigmaaldrich
murin
interleukin
peprotech
plate
immobil
goat
antimous
captur
antibodi
cultur
incub
overnight
order
lyse
cell
plate
wash
three
time
tween
h
report
viru
seegfp
dilut
iuml
infecti
unit
per
ml
incub
plate
h
unbound
viru
remov
three
wash
step
hff
cell
seed
plate
densiti
cell
per
well
two
day
incub
foci
visual
axio
observ
microscop
zeiss
oberkochen
germani
visual
footprint
one
well
six
pictur
taken
magnif
merg
micropl
highbind
black
greiner
bio
one
coat
goat
f
antihuman
igg
specif
jackson
immunoresearch
west
grove
pa
usa
mm
carbon
buffer
ph
overnight
nonspecif
bind
block
pb
contain
milk
powder
sigma
aldrich
h
room
temperatur
block
solut
remov
cell
transient
express
hcmv
specif
human
igg
seed
micropl
serial
dilut
parallel
stabli
transfect
cell
secret
human
antibodi
mab
seed
serv
unspecif
control
cell
incub
two
day
order
lyse
cell
plate
wash
tween
h
three
time
report
viru
dilut
iuml
infecti
unit
per
ml
incub
plate
h
unbound
viru
remov
three
wash
step
hff
cell
seed
plate
densiti
cell
per
well
two
day
incub
foci
visual
axio
observ
microscop
zeiss
oberkochen
germani
visual
footprint
one
well
six
pictur
taken
magnif
merg
identif
antigenspecif
antibodysecret
cell
bcell
hybridoma
cell
transfect
plasmid
encod
igggen
crucial
step
process
isol
highli
neutral
antibodi
facilit
step
therebi
promot
gener
novel
broadli
neutral
antibodi
hsv
hcmv
establish
two
screen
approach
identifi
virusspecif
antibodysecret
cell
sinc
entri
hsv
hcmv
highli
complex
process
involv
sever
viral
surfac
protein
use
intact
viru
particl
screen
procedur
strategi
allow
identifi
antibodi
direct
complex
entri
machineri
includ
miscellan
conform
epitop
virusbas
elisa
identif
hsvspecif
cell
identif
hsvspecif
cell
establish
elisa
base
detect
hsvspecif
antibodi
bound
immobil
viru
fig
assay
design
screen
antibodysecret
cell
cell
cultur
supernat
hsvspecif
antibodi
microtit
plate
coat
lack
hsvfcreceptor
gegi
complex
minim
unspecif
bind
antibodi
fig
bind
iggfc
domain
hsvfcreceptor
speciesspecif
contrast
murin
antibodi
human
igg
bind
fcreceptor
spragu
et
al
exclud
unspecif
bind
work
human
antibodysecret
cell
antibodi
subsequ
studi
decid
establish
assay
mutant
immobil
viru
fix
overlaid
murin
human
antibodysecret
cell
cell
incub
h
immobil
viru
fig
subsequ
antibodysecret
cell
hsvunspecif
antibodi
remov
fig
bound
hsvspecif
antibodi
detect
peroxidas
conjug
secondari
antibodi
fig
cell
cultur
posit
virusspecif
antibodi
subsequ
dilut
singl
cell
level
expand
retest
specif
antibodi
select
product
monoclon
antibodi
virusbas
elisa
assay
suitabl
identifi
cell
hybridoma
cell
bcell
clone
transfect
cell
secret
hsvspecif
antibodi
direct
viral
surfac
antigen
method
establish
detect
cell
secret
murin
human
antibodi
model
system
cell
secret
murin
human
antibodi
use
murin
hybridoma
cell
line
stabli
transfect
cell
line
produc
human
antibodi
mab
antibodi
specif
conform
epitop
glycoprotein
b
eishubing
et
al
krawczyk
et
al
krawczyk
et
al
microtit
plate
coat
immobil
incub
distinct
number
either
cell
cell
secret
murin
human
specif
antibodi
cell
mix
respect
number
murin
friendvirusspecif
hybridoma
cell
human
cell
secret
monoclon
antibodi
specif
unspecif
control
reach
equal
number
cell
per
well
cell
alon
serv
background
control
cutoff
defin
twofold
valu
unspecif
background
measur
cell
respect
assay
prove
reliabl
detect
five
murin
hybridoma
fig
ten
cell
secret
human
antibodi
specif
fig
total
number
cell
test
perform
three
time
triplic
similar
result
demonstr
reproduc
assay
slight
background
signal
observ
use
cell
alon
conclud
screen
procedur
perform
high
throughput
assay
identifi
hsvspecif
antibodysecret
cell
determin
detect
limit
sensit
virusbas
elisa
incub
variou
concentr
nm
murin
mab
human
mab
immobil
bind
hsvspecif
antibodi
immobil
viru
quantifi
activ
peroxidaseconjug
secondari
antibodi
cutoff
defin
threefold
valu
pb
signal
found
bound
mab
detect
concentr
nm
fig
mab
concentr
nm
fig
howev
unspecif
bind
antibodi
direct
hsv
might
lead
fals
posit
result
particularli
low
concentr
rang
investig
impact
unspecif
antibodi
bind
repeat
measur
compar
bind
properti
mab
mab
murin
friend
virusspecif
antibodi
human
antibodi
specif
detect
limit
defin
threefold
valu
pb
control
specif
bind
could
detect
concentr
nm
mab
fig
mab
fig
slightli
background
signal
observ
concentr
nm
howev
consider
lower
mab
mab
signal
concentr
data
demonstr
virusbas
elisa
reliabl
method
detect
cell
secret
murin
humanhuman
antibodi
specif
surfac
antigen
includ
recogn
conform
epitop
method
also
suitabl
detect
antibodi
cell
cultur
supernat
identifi
novel
broadli
neutral
monoclon
antibodi
hcmv
establish
hcmvgfpreport
virusbas
assay
assay
design
identifi
cell
secret
antibodi
microtit
plate
coat
immobil
viru
incub
variou
number
cell
secret
specif
antibodi
murin
hybridoma
cell
secret
gbspecif
antibodi
mix
hybridoma
cell
secret
friend
virusspecif
murin
antibodi
c
stabli
transfect
cell
secret
gbspecif
human
antibodi
mab
mix
cell
secret
human
antibodi
specif
total
cell
number
cellswel
cell
alon
serv
background
control
h
incub
cell
lyse
virusbound
antibodi
detect
peroxidas
conjug
secondari
antibodi
specif
murin
human
c
iggfcfrag
b
serial
dilut
purifi
mous
antibodi
mab
human
counterpart
mab
incub
immobil
bound
antibodi
detect
describ
experi
perform
triplic
detect
limit
given
threefold
valu
pb
signal
red
line
valu
given
averag
triplic
error
bar
indic
standard
deviat
mean
sdm
interpret
refer
colour
figur
legend
reader
refer
web
version
articl
fig
sensit
base
elisa
decreas
concentr
nm
purifi
gb
specif
murin
antibodi
mab
human
antibodi
mab
b
incub
immobil
murin
friend
virusspecif
control
antibodi
human
antibodi
specif
b
use
gener
background
valu
dilut
nm
experi
perform
triplic
detect
limit
given
threefold
valu
pb
signal
red
line
error
bar
indic
standard
deviat
mean
sdm
interpret
refer
colour
figur
legend
reader
refer
web
version
articl
direct
hcmv
surfac
glycoprotein
comprehens
cell
repertoir
murin
cell
hybridoma
cell
librari
ebvimmort
bcell
preselect
blood
donor
basic
assay
reli
fact
indic
cell
becom
infect
fluoresc
hcmv
report
viru
site
cell
secret
hcmvspecif
antibodi
left
antibodi
footprint
fig
microtit
plate
coat
gamor
captur
antibodi
overlaid
cell
cultur
includ
cell
secret
antihcmv
specif
antibodi
fig
secret
antibodi
bound
solid
phasefix
captur
antibodi
therebi
cell
leav
antibodyfootprint
place
sediment
fig
remov
cell
captur
antibodi
overlaid
cell
cultur
medium
contain
hcmvgfp
report
viru
viru
bind
captur
antibodi
specif
hcmv
surfac
antigen
fig
subsequ
unbound
viru
remov
wash
indic
hff
cell
seed
onto
immobil
antibodyviru
complex
fig
therebi
cell
infect
attach
cellfootprint
bound
virion
previou
step
fig
subsequ
hffcell
infect
hcmv
report
viru
produc
gfp
henc
visual
count
fluoresc
microscopi
fig
cell
cultur
identifi
produc
virusspecif
antibodi
subsequ
dilut
singl
cell
level
expand
retest
select
product
hcmvspecif
monoclon
antibodi
assay
establish
use
murin
hybridoma
clone
secret
antibodi
specif
hcmv
envelop
glycoprotein
h
gh
falk
et
al
first
seri
three
experi
test
whether
concept
detect
hcmvspecif
antibodi
footprint
valid
foci
infect
cell
form
seed
hybridoma
cell
specif
hcmv
surfac
protein
microtit
plate
coat
gamfcyspecif
captur
antibodi
hybridoma
cell
seed
densiti
cell
per
well
incub
overnight
hybridoma
cell
expect
secret
antibodi
bound
captur
antibodi
thu
leav
antibodi
footprint
posit
sediment
hcmvghspecif
hybridoma
cell
clone
serv
posit
control
respect
antibodi
bind
surfac
virion
hybridoma
cell
clone
serv
background
control
releas
antibodi
direct
hcmv
tegument
protein
access
surfac
virion
addit
mixtur
hybridoma
cell
appli
seed
cell
clone
togeth
cell
clone
per
well
overnight
incub
hybridoma
cell
remov
deterg
lysi
captur
antibodi
overlaid
report
viru
seegfp
h
viru
expect
bind
exclus
captur
hybridoma
footprint
clone
contrast
antibodi
clone
expect
bind
surfac
virion
therefor
caus
infect
foci
indic
cell
layer
hff
indic
cell
seed
onto
plate
assumpt
cell
would
infect
lie
footprint
bound
virion
two
day
later
gfpproduc
infect
cell
visual
fluoresc
microscopi
fig
expect
foci
infect
cell
detect
well
cell
clone
seed
indic
nonspecif
focal
bind
report
virion
occur
condit
dispers
gfpposit
cell
could
detect
fig
contrast
seed
hybridoma
clone
alway
result
format
infecti
foci
cell
clone
seed
numer
foci
visibl
could
distinguish
fig
cell
clone
seed
togeth
excess
clone
foci
infect
microtit
plate
coat
goat
antimous
fcyspecif
captur
antibodi
hybridoma
cell
clone
specif
hcmv
surfac
protein
gh
seed
densiti
cell
per
well
b
cell
seed
densiti
cell
per
well
togeth
hybridoma
cell
clone
specif
hcmv
tegument
protein
c
well
seed
cell
per
well
clone
serv
neg
control
h
incub
hybridoma
cell
remov
lysi
medium
contain
hcmvbac
egfp
report
viru
ad
h
unbound
report
viru
remov
hff
indic
cell
seed
h
hcmvinfect
gfpproduc
hff
detect
fluoresc
microscopi
six
imag
compil
visual
whole
well
facilit
evalu
photo
shown
invert
mode
ie
dark
dot
repres
gfpexpress
cell
focu
gfpexpress
cell
assum
repres
one
hybridoma
cell
footprint
cell
clearli
distinguish
number
foci
fit
assumpt
report
viru
would
focal
adher
site
cell
sediment
fig
taken
togeth
hybridoma
cell
secret
antibodi
hcmv
envelop
protein
reliabl
induc
format
infect
foci
within
indic
cell
layer
wherea
dispers
infect
cell
found
background
control
probabl
due
individu
virion
remain
plate
wash
procedur
order
demonstr
antibodyfootprint
assay
also
suitabl
detect
human
cell
secret
hcmv
specif
human
igg
use
transient
transfect
cell
express
hcmv
specif
human
antibodi
igg
macagno
et
al
antibodi
direct
pentamer
glycoprotein
complex
surfac
hcmv
control
stabli
transfect
cell
secret
gbspecif
human
antibodi
mab
use
well
contain
cell
secret
igg
numer
foci
could
found
could
distinguish
fig
well
contain
cell
secret
igg
foci
infect
cell
distinguish
fig
expect
foci
infect
cell
detect
well
mab
cell
seed
indic
unspecif
bind
report
viru
condit
dispers
gfpposit
cell
could
detect
fig
result
clearli
demonstr
method
present
suitabl
detect
cell
secret
human
igg
specif
complex
epitop
hcmv
surfac
sinc
hybridoma
cell
robust
compar
transient
transfect
cell
sensit
assay
determin
use
hybridoma
cell
follow
therefor
test
whether
assay
reliabl
detect
singl
hcmv
surfacespecif
hybridoma
cell
within
great
number
surfaceunspecif
hybridoma
cell
simul
situat
hcmvenvelopespecif
bcell
hidden
excess
nonspecif
cell
mix
distinct
number
hcmv
ghspecif
hybridoma
cell
surplu
hybridoma
cell
specif
hcmv
tegument
protein
reach
total
number
cell
per
well
h
cultiv
cell
lyse
deterg
solut
antibodi
footprint
hybridoma
cell
overlaid
h
gfpreport
viru
allow
bind
virion
site
cell
locat
wash
addit
indic
fibroblast
incub
two
day
cultur
screen
gfpexpress
cell
fluoresc
microscop
number
infecti
foci
count
fig
expectedli
number
visibl
footprint
increas
number
hybridoma
cell
per
well
probabl
seed
hybridoma
cell
would
form
focu
infect
cell
around
concentr
ie
seed
hybridoma
cell
reliabl
result
format
foci
three
repeat
experi
even
singl
cell
seed
among
cell
focu
detect
experi
indic
assay
suitabl
detect
hcmv
surfac
antigenspecif
specif
bcell
cell
mixtur
exampl
bcell
donor
direct
envelop
protein
hcmv
cell
screen
well
contain
cell
probabl
find
hcmvspecif
bcell
calcul
easili
feasibl
assay
present
studi
establish
two
distinct
method
detect
cell
secret
antibodi
specif
viral
surfaceantigen
hsv
hcmv
infect
hsv
hcmv
may
lead
sever
even
lifethreaten
diseas
immunocompromis
patient
acquir
birth
hsv
pregnanc
hcmv
berrington
et
al
bhat
et
al
boppana
et
al
thompson
whitley
antivir
avail
may
lead
develop
resist
minc
et
al
morfin
thouvenot
contraind
treatment
pregnanc
due
potenti
teratogen
side
effect
kimberlin
antibodybas
strategi
reveal
highli
promis
fight
viral
infect
numer
potent
neutral
antibodi
hiv
sarscov
ebola
viru
viral
pathogen
isol
within
past
year
bornholdt
et
al
caskey
et
al
traggiai
et
al
preclin
earli
phase
clinic
trial
hyperimmunoglobulin
monoclon
antibodi
target
hsv
hcmv
also
shown
promis
result
krawczyk
et
al
masci
et
al
nigro
et
al
revello
et
al
howev
identif
novel
highli
neutral
antibodi
virus
would
great
benefit
significantli
improv
antivir
treatment
commonli
monoclon
antibodi
deriv
ebvimmort
human
bcell
collect
seroposit
patient
recov
infect
immun
mice
marasco
sui
therefor
screen
select
process
crucial
step
identifi
antigenspecif
bcell
whole
bcell
repertoir
seroposit
human
immun
mice
limit
time
particularli
look
bcell
secret
antibodi
target
complex
discontinu
epitop
viral
surfac
antigen
function
assay
microneutr
assay
use
contribut
isol
potent
neutral
antibodi
hcmv
macagno
et
al
altern
perform
neutral
assay
may
requir
high
amount
purifi
antibodi
bcell
cellcultur
supernat
screen
antigen
bind
convent
elisa
assay
well
establish
routin
diagnost
usual
base
purifi
viral
antigen
liermann
et
al
high
throughput
screen
techniqu
base
antigen
microarray
develop
facilit
screen
process
de
masi
et
al
tickl
et
al
method
allow
simultan
screen
bcell
antibodi
specif
one
particular
antigen
sever
antigen
howev
sinc
assay
base
purifi
recombin
peptid
protein
inadequ
detect
neutral
antibodi
target
complex
surfaceantigen
epitop
respect
identifi
novel
highli
neutral
antibodi
hsv
hcmv
establish
two
screen
method
base
full
virus
allow
detect
antibodi
target
complex
entri
machineri
virus
includ
miscellan
conform
epitop
notabl
prior
studi
report
highli
potent
antibodi
hsv
hcmv
bind
complex
discontinu
epitop
one
one
viral
protein
cairn
et
al
krawczyk
et
al
macagno
et
al
accordingli
dengu
viru
denv
immun
serum
deplet
studi
shown
antibodi
respons
serum
neutral
activ
follow
primari
denv
infect
target
complex
epitop
exist
correct
conform
state
virion
particl
recombin
solubl
form
viral
surfac
antigen
e
smith
et
al
data
indic
might
great
benefit
work
full
virus
screen
bcell
clone
neutral
antibodi
work
herpesvirus
hsv
hcmv
one
keep
mind
virus
bind
antibodi
via
viral
fcreceptor
atalay
et
al
ndjamen
et
al
spragu
et
al
interact
viral
fcreceptor
immunoglobulin
speciesspecif
igg
human
exhibit
stronger
bind
hsvfcr
hcmvfcr
mous
igg
antonsson
johansson
johansson
et
al
fcrelat
unspecif
bind
elimin
use
fcreceptorlack
viru
block
viral
fcreceptor
human
fcfragment
sera
seroneg
donor
fcreceptor
consist
glycoprotein
dimer
gegi
well
character
gedelet
mutant
lack
viral
fcreceptor
avail
farnsworth
et
al
present
studi
work
mutant
exclud
unspecif
bind
relat
fcreceptor
signific
unspecif
bind
observ
use
human
antibodi
specif
indic
assay
reliabl
detect
virusspecif
antibodi
particular
sinc
number
hcmv
protein
describ
bind
human
iggfcdomain
appropri
delet
mutant
avail
decid
use
hcmvgfp
report
viru
although
could
observ
background
relat
hcmvreceptor
bind
hcmvunspecif
antibodi
studi
bind
easili
inhibit
preincub
report
viru
human
fcfragment
previous
describ
antonsson
johansson
indic
critic
point
identifi
hsv
hcmv
specif
antibodi
assay
describ
might
antibodi
affin
cell
secret
lowaffin
hsv
hcmv
specif
may
induc
weak
signal
thu
remain
undetect
howev
know
hiv
hsv
influenza
field
best
neutral
antibodi
bind
target
antigen
high
affin
least
nanomolar
rang
see
eg
mascola
hayn
assay
describ
develop
support
identif
novel
highli
neutral
antibodi
develop
clinic
use
line
prior
studi
expect
antibodi
bind
target
antigen
high
affin
affin
specif
mab
use
studi
nanomolar
rang
krawczyk
et
al
affin
hcmvspecif
igg
could
yet
determin
base
prior
studi
estim
also
nanomolar
rang
macagno
et
al
therefor
conclud
method
describ
manuscript
suitabl
detect
highaffin
antibodi
target
hsv
hcmv
summari
whole
virusbas
screen
assay
describ
studi
highli
sensit
allow
detect
one
ten
cell
secret
murin
humanhuman
antibodi
specif
hcmv
cell
mixtur
posit
select
highaffin
binder
newli
identifi
antibodi
need
character
potent
viru
neutral
select
potenti
candid
clinic
use
method
describ
may
facilit
screen
procedur
bcell
specif
hsv
hcmv
surfac
antigen
includ
target
highli
complex
epitop
structur
contribut
toward
identifi
novel
potent
antibodi
hsv
hcmv
supplementari
data
articl
found
onlin
http
fig
sensit
hcmvgfp
report
virusbas
footprint
assay
microtit
plate
coat
goat
captur
antibodi
vari
number
clone
hybridoma
cell
specif
hcmv
surfac
antigen
gh
mix
hcmv
surfac
antigenunspecif
hybridoma
cell
seed
microtit
plate
total
cell
number
cellswel
cell
remov
h
incub
captur
antibodi
overlaid
medium
contain
hcmvbac
egfp
report
viru
h
unbound
report
viru
remov
hff
indic
cell
seed
cultur
h
allow
onset
infect
total
number
gfpposit
footprintswel
count
fluoresc
microscopi
data
given
mean
two
independ
experi
perform
triplic
error
bar
repres
standard
error
mean
